Biomarkers for Bisphosphonate-Related Osteonecrosis of the Jaw

33Citations
Citations of this article
54Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Purpose: The aim of this study was to investigate a possible biomarker for bisphosphonate-related osteonecrosis of the jaw (BRONJ) in an animal model. Materials and Methods: Forty-eight Sprague-Dawley rats were randomly divided into the bisphosphonate group (n=36), who were injected once a week with zoledronic acid, and the control group (n=12), who were injected once a week with saline. After 6 weeks, surgical intervention was performed, and injections were continued up to 8 weeks. Rats in the bisphosphonate group were then further classified to the ONJ group, and the non-ONJ group, and biomarkers, including CTx, Glu-OC, TRACP 5b, RANKL, and OPG, were assessed at baseline (T0), at surgical intervention (T1), and at sacrifice (T2). Histomorphometric analysis for quantification of osteoclasts was performed. Results: Repeated measures analysis of variance revealed that TRACP 5b levels and the RANKL/OPG ratio were significantly decreased over time in the ONJ group compared with the non-ONJ group (p

Cite

CITATION STYLE

APA

Kim, J. W., Cha, I. H., Kim, S. J., & Kim, M. R. (2016). Biomarkers for Bisphosphonate-Related Osteonecrosis of the Jaw. Clinical Implant Dentistry and Related Research, 18(2), 281–291. https://doi.org/10.1111/cid.12297

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free